Insights

Strategic Merger SeQuent Scientific merged with Viyash Scientific to expand its animal health platform, backed by Carlyle. This signals a larger market presence and potential cross-sell opportunities across expanded product lines and geographies.

Regulatory Footprint Vizag facility is India’s only US FDA approved dedicated veterinary API facility, highlighting strong quality credentials and potential for US and global contract manufacturing or API supply engagements.

Revenue Growth Current revenue range of $25M-$50M with multi-country manufacturing indicates room to scale through expanded product formulations, finished dosages, and higher-margin API services to global animal health players.

Leadership Stability Recent CFO changes and leadership appointments suggest ongoing financial governance and potential for enhanced financial reporting, cost optimization, and structured sales pitches around fiscal health and ROI for customers.

Product & Tech Alignment Diverse product portfolio including Halofusol and API capabilities, along with a tech stack featuring analytics and SEO tools, points to opportunities in digital marketing services, formulation development, and compliant API manufacturing partnerships.

Similar companies to Sequent Scientific Limited

Sequent Scientific Limited Tech Stack

Sequent Scientific Limited uses 8 technology products and services including iCIMS, WordPress, CookieYes, and more. Explore Sequent Scientific Limited's tech stack below.

Media & News

Sequent Scientific Limited's Email Address Formats

Sequent Scientific Limited uses at least 5 email formats:
Sequent Scientific Limited Email FormatsExamplePercentage
Last.F@sequent.inDoe.J@sequent.in
53%
First.Last@sequent.inJohn.Doe@sequent.in
36%
First.L@sequent.inJohn.D@sequent.in
8%
FirstL@sequent.inJohnD@sequent.in
3%
First.Last@viyash.comJohn.Doe@viyash.com
100%

Frequently Asked Questions

What is Sequent Scientific Limited's official website and social media links?

Minus sign iconPlus sign icon
Sequent Scientific Limited's official website is viyash.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Sequent Scientific Limited generate?

Minus sign iconPlus sign icon
As of August 2026, Sequent Scientific Limited's annual revenue is estimated to be $25M - $50M.

What is Sequent Scientific Limited's SIC code and NAICS code?

Minus sign iconPlus sign icon
Sequent Scientific Limited's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Sequent Scientific Limited have currently?

Minus sign iconPlus sign icon
As of August 2026, Sequent Scientific Limited has approximately 982 employees across 3 continents, including Asia, North America and Europe. Key team members include Chief Operating Officer Commercial: M. B., Vice President Operations: S. V. and Head - Legal, Secretarial, Compliance, Csr & Chief Risk Officer: P. T. Explore Sequent Scientific Limited's employee directory with LeadIQ.

What industry does Sequent Scientific Limited belong to?

Minus sign iconPlus sign icon
Sequent Scientific Limited operates in the Pharmaceutical Manufacturing industry.

What technology does Sequent Scientific Limited use?

Minus sign iconPlus sign icon
Sequent Scientific Limited's tech stack includes iCIMS, WordPress, CookieYes, Osano, Microsoft 365, SendGrid, React and Piwik PRO Core.

What is Sequent Scientific Limited's email format?

Minus sign iconPlus sign icon
Sequent Scientific Limited's email format typically follows the pattern of Last.F@sequent.in. Find more Sequent Scientific Limited email formats with LeadIQ.

When was Sequent Scientific Limited founded?

Minus sign iconPlus sign icon
Sequent Scientific Limited was founded in 2002.
Sequent Scientific Limited logo

Sequent Scientific Limited

Pharmaceutical ManufacturingIndia501-1000 Employees

SeQuent Scientific Limited is an Indian-based pharmaceutical manufacturer specializing in animal health, offering finished drug formulations, active pharmaceutical ingredients, and analytical services to the global market. The company operates eight manufacturing facilities across Europe, Turkey, Brazil, and India, including Vizag in India, which hosts the country's only US FDA-approved dedicated veterinary API facility. Backed by The Carlyle Group as promoter, SeQuent is positioned as India's largest animal health company and among the top 20 globally.

Its customers are global animal health companies seeking veterinary APIs, formulations, and related analytical services, supported by a multinational production footprint that serves international markets from its Indian base. In 2024, SeQuent completed a merger with Viyash Scientific Ltd to form a larger animal pharmaceuticals platform.

Section iconCompany Overview

Website
viyash.com
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2002
Employees
501-1000

Section iconFunding & Financials

  • $25M - $50M

    Sequent Scientific Limited's revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.